18 participants
An Open-Label Extension Study to Evaluate the Long-term Safety and Efficacy of BMN 351 in Participants With Duchenne Muscular Dystrophy
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-07-24
- Start Date:
- 2026-04-20
- Completion:
- 2031-12-31
Conditions
- Duchenne Muscular Dystrophy (DMD)
Interventions
- DRUG
No Results Yet